FABP4 and diabetes mellitus: On the other hand, depletion of macrophages only led to a modest reduction in the incidence rate of diabetes (39.4% in GdCl3-treated vs. 49.8% in vehicle-treated group) and a slight improvement in glucose tolerance in FABP4–/–NOD mice (Figure 6, C–E).